ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017
Trading in the financial instruments of Mithra Pharmaceuticals, ISIN BE0974283153, on Euronext Brussels is suspended on the request of the company from 30/10/2023 at 13:30 CET until the publication of a press release.
